Clinical Trial: Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Bronchial Alveolar Carcinoma of the Lung

Brief Summary:

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells.

PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have recurrent or stage IV lung cancer.